European Journal of Medicinal Chemistry
Feb 17, 2016 Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton. Eur J Med Chem 2014;81:245–52 W. J. Burke, M. J. Kolbezen, C. Wayne Stephens, J. Am. Chem. Mathew, A. Kumar, S. Sharma, P. K. Shukla, M. Nath, Eur. J. Med. Chem. 45 (2010) 1502– 1507 Received 19 Nov 2010, Accepted 20 Jan 2011, Published 15 Feb 2011 D. J. Eur. J. Med. Chem. 2004, 39, 1059–1065. doi:10.1016/j.ejmech.2004.09.007 structure on biological activity and in the practice of medicinal chemistry [31] H. M. Refaat, European Journal of Medicinal Chemistry., 2010, 45, 2949-2956. 2008-2010. (k) A reviewer in many journals including,. Nature Chemistry;. J. Med. Chem.;. J. Phys. Chem.;. Inorg. Chem.;. Chemistry, A European Journal;.
Read the latest articles of European Journal of Medicinal Chemistry at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature European Journal of Medicinal Chemistry | All Journal ... Read the latest articles of European Journal of Medicinal Chemistry at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature European Journal of Medicinal Chemistry [4].Thecompound[4]wasfurthercyclizedwithmercptoaceticacid in presence of anhydrous ZnCl2 to afford thiazolidinone derivative [5], further compound [5] on treatment European Journal of Medicinal Chemistry | ScienceDirect.com Read the latest articles of European Journal of Medicinal Chemistry at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
European Journal of Medicinal Chemistry 115, 484, 2016 [77]. Singh, P.; Kaur, M.; Holzer, W. Eur. J. Med. Chem. 2010, 45, 4968-4082. The European Journal of Medicinal Chemistry publishes studies on all aspects 2011 Impact Factor 3.845; 2010 Impact Factor 3.484; 2009 Impact Factor 3.366 Nov 28, 2018 European Journal of Medicinal Chemistry. 2010, 45; 2048–2054. [52]. A. Puratchikody and M. Doble. Antinociceptive and antiinflammatory Feb 17, 2016 Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton. Eur J Med Chem 2014;81:245–52 W. J. Burke, M. J. Kolbezen, C. Wayne Stephens, J. Am. Chem. Mathew, A. Kumar, S. Sharma, P. K. Shukla, M. Nath, Eur. J. Med. Chem. 45 (2010) 1502– 1507 Received 19 Nov 2010, Accepted 20 Jan 2011, Published 15 Feb 2011 D. J. Eur. J. Med. Chem. 2004, 39, 1059–1065. doi:10.1016/j.ejmech.2004.09.007
Read the latest articles of European Journal of Medicinal Chemistry at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Received 19 Nov 2010, Accepted 20 Jan 2011, Published 15 Feb 2011 D. J. Eur. J. Med. Chem. 2004, 39, 1059–1065. doi:10.1016/j.ejmech.2004.09.007 structure on biological activity and in the practice of medicinal chemistry [31] H. M. Refaat, European Journal of Medicinal Chemistry., 2010, 45, 2949-2956. 2008-2010. (k) A reviewer in many journals including,. Nature Chemistry;. J. Med. Chem.;. J. Phys. Chem.;. Inorg. Chem.;. Chemistry, A European Journal;. Aug 14, 2016 Eur J Med Chem. 2010; 45: 3365-73. Anand T, Sivaraman G, Chellappa D. Quinazoline copper(II) ensemble as turn-on fluorescence sensor for the areas of organic synthesis, chemical biology and medicinal chemistry. K. Kalia, A. K. Sinha and D. Sahal, Eur. J. Med. Chem. 2010, 45, 5292-5301. Eur J Med Chem. 2010; 45: 1374-. 1378. 13. Kumar K, Carrere-Kremer S, Kremer L, Guerardel Y, Biot. C, Kumar V. 1H-1,2,3-triazole-tethered isatin-ferrocene.